Replies to post #74082 on Avid Bioservices Inc (CDMO)

[pphmtoolong]

Fact -- Pivotal double-blind NSCLC trial if fully enrolled and heading for conclusion in a few months. Fact -- there is nothing the SOC can do for these patients. Fact -- Bavi has consistently shown efficacy in every cancer it has been tried on. Fact -- if Bavi strikes again, Peregrine will have something of value.

Paul

[djohn]

I agree that is a fact. eom